local_hospital

Berliner Centrum Fur Reise Und Tropenmedizin GmbH

Address
lock Available on a paid plan

Respiratory Tract Diseases and Virus Diseases

At Berliner Centrum Fur Reise Und Tropenmedizin GmbH, clinical research in respiratory infections and viral diseases focuses on protecting older adults from common and serious infections such as influenza and respiratory syncytial virus.

  • Testing new vaccines designed to prevent influenza illness and support better protection in adults.
  • Evaluating approaches for RSV and human metapneumovirus to reduce lower respiratory tract disease.
  • Assessing immune response and safety in studies that aim to improve prevention of seasonal respiratory infections.

These trials are centered on vaccine effectiveness, immune response, and infection prevention in populations at higher risk of complications.

Cytomegalovirus Research

This site also supports research in cytomegalovirus infection, with studies aimed at preventing primary infection and understanding how well candidate vaccines are tolerated and recognized by the immune system.

  • Studying a vaccine approach to help prevent CMV infection in seronegative women.
  • Monitoring safety and immunogenicity to see how well the body responds to the vaccine.
  • Generating evidence to support future strategies for reducing congenital CMV risk.

The research at this Berlin clinic combines infectious disease expertise with practical prevention goals, especially for viruses that can cause significant illness across different age groups.

Site Overview

assignment
5
connected trials
corporate_fare
5
sponsors
science
12
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
5
Total trials linked
Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
5
Active sponsors
2

Sponsor Network

Top 2 by active trials.

lock +1 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 2 161 other sites in Germany

description
Trial volume
5
Outperforms 72% of sites
public
Therapeutic diversity
2areas
Outperforms 62% of sites
groups
Sponsor diversity
5sponsors
Outperforms 76% of sites

Therapeutic Area Benchmark — Germany

Select a therapeutic area to compare against other sites in Germany.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Germany

Market Share

Country: Germany

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Berliner Centrum Fur Reise Und Tropenmedizin GmbH

lock Showing 1 of 5 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Controlled Study of Immunogenicity and Safety of the Investigational vYF Candidate Vaccine in Comparison to Stamaril® in AdultsSanofi PasteurPhase IINot RecruitingOct 2021

IMP list

lock Showing 1 of 12 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
A/Victoria/4897/2022 (H1N1)Pdm09-Like Strain (A/Victoria/4897/2022, Ivr-238)1Unknown2024-10-112024-10-11

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.